(Q48420144)

English

Blood pressure and plasma renin activity responses to different strategies to inhibit the renin-angiotensin-aldosterone system during exercise

scientific article published on 2 August 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

Blood pressure and plasma renin activity responses to different strategies to inhibit the renin-angiotensin-aldosterone system during exercise (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

object named as

Peter S Lacy

3

0 references

1

object named as

Bryan Williams

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

author name string

Fabio Baschiera

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

Jaco Botha

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

Margaret F Prescott

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

Patrick Brunel

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

publication date

2 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

Journal of the Renin-Angiotensin-Aldosterone System

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

14

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

56-66

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

Cardiovascular disease risk factors and blood pressure response during exercise in healthy children and adolescents: the European Youth Heart Study.

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Systolic blood pressure response to exercise stress test and risk of stroke

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Renin inhibition with aliskiren: where are we now, and where are we going?

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Renin inhibition in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Exaggerated blood pressure response to exercise is associated with augmented rise of angiotensin II during exercise.

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Blood Pressure Response During Treadmill Testing as a Risk Factor for New-Onset Hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

1 reference

https://api.crossref.org/works/10.1177%2F1470320312454766

21 January 2018

Identifiers

10.1177/1470320312454766

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22859712

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48420144&oldid=2244868382"